Sisto, M., Lisi, S., D'Amore, M., & Lofrumento, D. D. (2014). Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome. BlackWell Publishing Ltd.
استشهاد بنمط شيكاغوSisto, Margherita, Sabrina Lisi, Massimo D'Amore, و Dario D. Lofrumento. Rituximab-mediated Raf Kinase Inhibitor Protein Induction Modulates NF-κB in Sjögren Syndrome. BlackWell Publishing Ltd, 2014.
MLA استشهادSisto, Margherita, Sabrina Lisi, Massimo D'Amore, و Dario D. Lofrumento. Rituximab-mediated Raf Kinase Inhibitor Protein Induction Modulates NF-κB in Sjögren Syndrome. BlackWell Publishing Ltd, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.